Cargando…
Malignant deep brain stimulator withdrawal syndrome
Parkinsonism-hyperpyrexia syndrome (PHS) is a neurologic potentially fatal emergency that mimics neuroleptic malignant syndrome. It commonly presents as systemic inflammatory response syndrome, acute onset worsening of muscular rigidity, autonomic instability, hyperpyrexia, confusion, diaphoresis an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536166/ https://www.ncbi.nlm.nih.gov/pubmed/31092485 http://dx.doi.org/10.1136/bcr-2018-229122 |
_version_ | 1783421715632619520 |
---|---|
author | Azar, Jehad Elinav, Hila Safadi, Rifaat Soliman, Mona |
author_facet | Azar, Jehad Elinav, Hila Safadi, Rifaat Soliman, Mona |
author_sort | Azar, Jehad |
collection | PubMed |
description | Parkinsonism-hyperpyrexia syndrome (PHS) is a neurologic potentially fatal emergency that mimics neuroleptic malignant syndrome. It commonly presents as systemic inflammatory response syndrome, acute onset worsening of muscular rigidity, autonomic instability, hyperpyrexia, confusion, diaphoresis and high creatine phosphokinase. The most common trigger for PHS is reduction or withdrawal of anti-Parkinson’s medications, especially levodopa. It was also reported in a few cases following deep brain stimulation of the subthalamic nucleus surgery shortly after anti-Parkinson’s medications were discontinued. Rare causes of PHS include deep brain stimulator (DBS) malfunction due to battery depletion. To the best of our knowledge, PHS following DBS battery depletion was reported only in three occasions. Here, we report a case of PHS due to DBS battery depletion presented as sepsis and was successfully treated with the administration of dopamine agonists, intravenous fluids and changing the DBS battery. |
format | Online Article Text |
id | pubmed-6536166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-65361662019-06-12 Malignant deep brain stimulator withdrawal syndrome Azar, Jehad Elinav, Hila Safadi, Rifaat Soliman, Mona BMJ Case Rep New Disease Parkinsonism-hyperpyrexia syndrome (PHS) is a neurologic potentially fatal emergency that mimics neuroleptic malignant syndrome. It commonly presents as systemic inflammatory response syndrome, acute onset worsening of muscular rigidity, autonomic instability, hyperpyrexia, confusion, diaphoresis and high creatine phosphokinase. The most common trigger for PHS is reduction or withdrawal of anti-Parkinson’s medications, especially levodopa. It was also reported in a few cases following deep brain stimulation of the subthalamic nucleus surgery shortly after anti-Parkinson’s medications were discontinued. Rare causes of PHS include deep brain stimulator (DBS) malfunction due to battery depletion. To the best of our knowledge, PHS following DBS battery depletion was reported only in three occasions. Here, we report a case of PHS due to DBS battery depletion presented as sepsis and was successfully treated with the administration of dopamine agonists, intravenous fluids and changing the DBS battery. BMJ Publishing Group 2019-05-15 /pmc/articles/PMC6536166/ /pubmed/31092485 http://dx.doi.org/10.1136/bcr-2018-229122 Text en © BMJ Publishing Group Limited 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | New Disease Azar, Jehad Elinav, Hila Safadi, Rifaat Soliman, Mona Malignant deep brain stimulator withdrawal syndrome |
title | Malignant deep brain stimulator withdrawal syndrome |
title_full | Malignant deep brain stimulator withdrawal syndrome |
title_fullStr | Malignant deep brain stimulator withdrawal syndrome |
title_full_unstemmed | Malignant deep brain stimulator withdrawal syndrome |
title_short | Malignant deep brain stimulator withdrawal syndrome |
title_sort | malignant deep brain stimulator withdrawal syndrome |
topic | New Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536166/ https://www.ncbi.nlm.nih.gov/pubmed/31092485 http://dx.doi.org/10.1136/bcr-2018-229122 |
work_keys_str_mv | AT azarjehad malignantdeepbrainstimulatorwithdrawalsyndrome AT elinavhila malignantdeepbrainstimulatorwithdrawalsyndrome AT safadirifaat malignantdeepbrainstimulatorwithdrawalsyndrome AT solimanmona malignantdeepbrainstimulatorwithdrawalsyndrome |